Literature DB >> 6849378

Tissue sites of catabolism of albumin in rabbits.

S Yedgar, T E Carew, R C Pittman, W F Beltz, D Steinberg.   

Abstract

The sites of albumin catabolism were determined in rabbits using [14C]sucrose-labeled rabbit albumin. The [14C]sucrose moiety is not degradable and accumulates in tissues degrading the protein. Albumin was labeled with [14C]sucrose, and the monomeric form was selected for injection into rabbits. The validity of the sucrose-labeled albumin as a tracer for native albumin was shown by the similar plasma decay kinetics of 125I-labeled albumin derivatized with sucrose and 131I-labeled native albumin and by the similar decay kinetics for the biologically screened and unscreened preparations of [14C]sucrose-albumin. Two days after injection of [14C]sucrose-albumin, tissues were assayed for accumulated 14C-labeled degradation products soluble in trichloroacetic acid. All tissues catabolized albumin with no tissue of predominant importance; liver, kidney, and muscle were the largest contributors. Expressed in terms of activity per unit wet weight, adrenal, kidney, spleen, ovary, bone marrow, and liver were the most active. These most active tissues are those with fenestrated or discontinuous capillary beds, suggesting that exposure to high concentrations of albumin is an important determinant of their high rates of albumin degradation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849378     DOI: 10.1152/ajpendo.1983.244.1.E101

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

Review 1.  The thiol pool in human plasma: the central contribution of albumin to redox processes.

Authors:  Lucía Turell; Rafael Radi; Beatriz Alvarez
Journal:  Free Radic Biol Med       Date:  2013-06-07       Impact factor: 7.376

2.  A fluorescent residualizing label for studies on protein uptake and catabolism in vivo and in vitro.

Authors:  J L Maxwell; L Terracio; T K Borg; J W Baynes; S R Thorpe
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

3.  New thinking about postoperative hypoalbuminemia: a hypothesis of occult protein-losing enteropathy.

Authors:  Donald A Redelmeier
Journal:  Open Med       Date:  2009-11-24

4.  Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys.

Authors:  J D Wagner; T B Clarkson; R W St Clair; D C Schwenke; C A Shively; M R Adams
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 5.  Ineffectiveness of dietary protein augmentation in the management of the nephrotic syndrome.

Authors:  H Al-Bander; G A Kaysen
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

6.  Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.

Authors:  E A Wallnöfer; G C Thurner; C Kremser; H Talasz; M M Stollenwerk; A Helbok; N Klammsteiner; K Albrecht-Schgoer; H Dietrich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2020-10-11       Impact factor: 4.304

7.  In-vivo endocytosis by bristle-coated pits and intracellular transport of endogenous albumin in the endothelium of the sinuses of liver and bone marrow.

Authors:  P P De Bruyn; S Michelson; P W Bankston
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

8.  Quantification of the accumulation and degradation of beta-very-low-density lipoproteins in vivo using a 19F-containing residualizing label and n.m.r. spectroscopy.

Authors:  L A Meeh; J J Ackerman; S R Thorpe; A Daugherty
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

9.  Non-invasive detection of protein metabolism in vivo by n.m.r. spectroscopy. Application of a novel 19F-containing residualizing label.

Authors:  A Daugherty; N N Becker; L A Scherrer; B E Sobel; J J Ackerman; J W Baynes; S R Thorpe
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

10.  Inhibition of the metabolic degradation of filtered albumin is a major determinant of albuminuria.

Authors:  Julijana Vuchkova; Wayne D Comper
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.